Table 2 Genotypic and allelic frequencies of CD209 rs4804803 in CD and UC patients and in controls
From: CD209 in inflammatory bowel disease: a case-control study in the Spanish population
CD209 | Controls | CD | UC | Controls vs. CD | Controls vs. UC | |||
|---|---|---|---|---|---|---|---|---|
n = 731 | % | n = 515 | % | n = 497 | % | |||
AA | 446 | 0.61 | 293 | 0.57 | 294 | 0.59 | Overall, p = 0.27 | Overall, p = 0.54 |
AG | 251 | 0.34 | 191 | 0.37 | 184 | 0.37 | Carriers G, p = 0.14 OR = 1.19 (0.94–1.50) | Carriers G, p = 0.51 OR = 1.08 (0.85–1.37) |
GG | 34 | 0.05 | 31 | 0.06 | 19 | 0.04 | ||
A | 1143 | 0.78 | 777 | 0.75 | 772 | 0.78 | G vs. A, p = 0.11 OR = 1.17 (0.96–1.41) | G vs. A, p = 0.76 OR = 1.03 (0.84–1.26) |
G | 319 | 0.22 | 253 | 0.25 | 222 | 0.22 | ||